Human BCMA Protein, mFc Tag (PME100035)
Human BCMA, mFc Tag on SDS-PAGE under reducing condition
Human BAFF protein (100 μl/per well) (PME100043) binds to Human BCMA protein (PME100035) (EC50 0.03-15.625 ng/ml).
Human BCMA protein (2 μg/ml) (PME100035) binds to Anti-BCMA Neutralizing antibody (BME100028) (EC50 0.64-80.0 ng/ml).
FC analysis with 1μg/ml Human BCMA Protein on HEK293 cells transfected with human BAFF (Blue) or HEK293 transfected with irrelevant protein (Red).
Human GPR75-Strep full length protein-synthetic nanodisc (FLP120031)
Human GPR75-Strep-Nanodisc on SDS-PAGE
WB analysis of GPR75-Strep-Nanodisc with anti-GPR75 mAb (DMC100368)
Human GPR75-Strep-Nanodisc (0.2μg/per well) binds to anti-GPR75 mAb (DMC100368) (EC50 15.14ng/ml).
Loaded Human GPR75 mAb (DMC100368) on Pro-A Biosensor, binds human GPR75-Strep-synthetic nanodisc ( an affinity constant 5.02nM) .
Human CLDN18.2-Strep full length protein-PeptiNanodisc (FLP420014)
SDS-PAGE Analysis the Purity of CLDN18.2-PeptiNanodisc
CLDN18.2-PeptiNanodisc and CLDN18.2 mAb CLDN18.2-Peptidisc (0.2μg/per well) binds anti-CLDN18.2 mAb (DME100179) (EC50 60.34ng/ml).
Human CLDN6 full length protein -MNP (FLP100004)
Human CLDN6 membrane nanoparticles (0.5μg/per well) binds to anti-CLDN6 mAb (BME100082) (EC50 34.36ng/ml).
FACS analysis of CLDN6 MNPs
A. CLDN6 MNPs were stained only with secondary Ab. B. Control MNPs (2μg/mL) were stained with anti-CLDN6 antibody (BME100082), followed by secondary Ab. C. CLDN6 MNPs (2μg/mL) were stained with anti-GPRC5D antibody, followed by secondary Ab. D. CLDN6 MNPs (2μg/mL) were stained with anti-CLDN6 antibody (BME100082), followed by secondary Ab.
Human CLDN18.2 full length protein-VLP (FLP100006)
Human CLDN18.2 VLP (0.5ug/per well) binds to Anti-CLDN18.2 mAb (Zolbetuximab biosililar) (EC50 15.37ng/ml).
FACS analysis of CLDN18.2 VLP
A. CLDN18.2 VLP were stained only with PE secondary Ab.
B. Control VLP (1μg/mL) were stained with anti-CLDN18.2 antibody (Zolbetuximab biosimilar), followed by PE secondary Ab.
C. CLDN18.2 VLP (1μg/mL) were stained with anti-BCMA antibody, followed by PE secondary Ab.
D. CLDN18.2 VLP (1μg/mL) were stained with anti-CLDN18.2 antibody（Zolbetuximab biosimilar) , followed by PE secondary Ab.
Human CD24 full length protein-exo (FLP100002)
Human CD24 exosome (0.5μg/per well) binds to Anti-CD24 mAb (EC50 69.61ng/ml).
Nanoparticle Tracking Analysis of CD24 exosomes
TEM image of CD24 exosomes
